EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Governing biotechnology to provide safety and security and address ethical, legal, and social implications

Benjamin Trump, Christopher Cummings, Kasia Klasa, Stephanie Galaitsi, Igor Linkov

Frontiers in Genetics · 11.01.2023 · 13

DOI: 10.3389/fgene.2022.1052371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 11.01.2023. Verfasst von Benjamin Trump und 4 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research and Development Center, United States Army Corps of Engineers, Vicksburg, MS, United States. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The field of biotechnology has produced a wide variety of materials and products which are rapidly entering the commercial marketplace. While many developments promise revolutionary benefits, some of them pose uncertain or largely untested risks and may spur debate, consternation, and outrage from individuals and groups who may be affected by their development and use. In this paper we show that the success of any advanced genetic development and usage requires that the creators establish technical soundness, ensure safety and security, and transparently represent the product’s ethical, legal, and social implications (ELSI). We further identify how failures to address ELSI can manifest as significant roadblocks to product acceptance and adoption and advocate for use of the “safety-by-design” governance philosophy. This approach requires addressing risk and ELSI needs early and often in the technology development process to support innovation while providing security and safety for workers, the public, and the broader environment. This paper identifies and evaluates major ELSI challenges and perspectives to suggest a methodology for implementing safety-by-design in a manner consistent with local institutions and politics. We anticipate the need for safety-by-design approach to grow and permeate biotechnology governance structures as the field expands in scientific and technological complexity, increases in public attention and prominence, and further impacts human health and the environment.

Schlagwörter

Stichwörter der Autor:innen

ELSIbiotechnologygovernancepolicysafety-by-designsynthetic biology

Autor:innen und Institutionen

  • Engineering Research and Development Center, United States Army Corps of Engineers, Vicksburg, MS, United States.
  • Genetic Engineering and Society, North Carolina State University, Raleigh, NC, United States.
  • Gene Edited Foods Project, Iowa State University, Ames, IA, United States.
  • Department of Healthcare Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, United States.
  • Department of Engineering and Public Policy, Carnegie Mellon University, Pittsburgh, PA, United States.

Zitieren

APA

Trump, B., Cummings, C., Klasa, K., Galaitsi, S., & Linkov, I. (2023). Governing biotechnology to provide safety and security and address ethical, legal, and social implications. Frontiers in Genetics, 13. https://doi.org/10.3389/fgene.2022.1052371

Vancouver

Trump B, Cummings C, Klasa K, Galaitsi S, Linkov I. Governing biotechnology to provide safety and security and address ethical, legal, and social implications. Frontiers in Genetics. 2023;13. doi:10.3389/fgene.2022.1052371

BibTeX
@article{Trump2023,
  author = {Trump, Benjamin and Cummings, Christopher and Klasa, Kasia and Galaitsi, Stephanie and Linkov, Igor},
  title = {Governing biotechnology to provide safety and security and address ethical, legal, and social implications},
  journal = {Frontiers in Genetics},
  year = {2023},
  volume = {13},
  doi = {10.3389/fgene.2022.1052371}
}
Kostenlos starten →